Table 1.
Demographic and clinical details. N = no; Y = yes; Amp. = amputation; Amp. level: 1 = through shoulder, 2 = above elbow, 3 = through elbow, 4 = below elbow, 5 = wrist and below; Side = side of amputation; dominant = hand dominance prior to amputation (based on self-report); A = ambidextrous; L = left; R = right; PLS = phantom limb sensation; PLP = phantom limb pain; Inf. = infection; Pros. usage = prosthetics usage: 0 = never, 1 = rarely, 2 = occasionally, 3 = daily -less than 4 hours, 4 = daily - more than 4 hours, 5 = daily -over 8 hours; Treatment = pharmacological treatment for PLP.
| Tested in Makin, Scholz, et al. (2013) | Scanner | Age | Age at amp. | Amp. level | Side/dominant | PLS intensity | PLS frequency | Chronic PLS | PLP intensity | PLP frequency | Chronic PLP |
Transient PLP | Chronic residual arm (stump) pain | Cause of amp. | Pros. usage | Treatment | Telescoping | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A1 | N | Prisma | 71 | 53 | 2 | R/A | 20 | 1 | 20 | 85 | 2 | 42.5 | 20 | 0 | Trauma | 5 | N | Y |
| A2 | N | Prisma | 46 | 26 | 2 | R/R | 70 | 1 | 70 | 90 | 1 | 90 | 50 | 0 | Trauma | 5 | N | Y |
| A3 | N | Prisma | 64 | 31 | 2 | L/R | 100 | 1 | 100 | 40 | 5 | 8 | 10 | 0 | Trauma | 0 | N | Y |
| A4 | N | Prisma | 58 | 54 | 2 | L/R | 90 | 1 | 90 | 0 | 0 | 0 | 0 | 0 | Inf. | 0 | N | Y |
| A5 | N | Prisma | 57 | 26 | 2 | R/R | 80 | 1 | 80 | 90 | 5 | 18 | 40 | 0 | Trauma | 1 | N | Y |
| A6 | N | Prisma | 50 | 47 | 4 | L/R | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20 | Trauma | 4 | N | N |
| A7 | N | Prisma | 52 | 23 | 2 | R/R | 100 | 1 | 100 | 80 | 2 | 40 | 50 | 15 | Trauma | 0 | N | N |
| A8 | N | Prisma | 68 | 40 | 4 | R/R | 80 | 5 | 16 | 0 | 0 | 0 | 0 | 12.5 | Trauma | 4 | N | N |
| A9 | N | Prisma | 40 | 28 | 4 | R/L | 70 | 2 | 35 | 40 | 2 | 20 | 30 | 70 | Trauma | 0 | N | Y |
| A10 | N | Prisma | 47 | 30 | 4 | L/R | 80 | 1 | 80 | 30 | 1 | 30 | 30 | 8 | Trauma | 5 | N | Y |
| A11 | N | Verio | 41 | 27 | 2 | R/L | 100 | 1 | 100 | 80 | 1 | 80 | 60 | 100 | Trauma | 2 | N | N |
| A12 | N | Verio | 48 | 17 | 2 | L/R | 100 | 1 | 100 | 75 | 3 | 25 | 0 | 10 | Trauma | 2 | N | N |
| A13 | N | Verio | 37 | 27 | 2 | L/R | 90 | 1 | 90 | 40 | 3 | 13.3 | 10 | 16.7 | Trauma | 2 | N | Y |
| A14 | N | Verio | 64 | 33 | 4 | R/R | 75 | 1 | 75 | 0 | 0 | 0 | 0 | 0 | Trauma | 5 | N | Y |
| A15 | N | Verio | 29 | 24 | 1 | L/R | 80 | 2 | 40 | 70 | 4 | 17.5 | 0 | 0 | Trauma | 2 | N | Y |
| A16 | N | Verio | 32 | 31 | 2 | L/R | 100 | 1 | 100 | 100 | 2 | 50 | 10 | 0 | Trauma | 2 | Y | N |
| A17 | Y | Prisma | 59 | 44 | 4 | L/R | 10 | 5 | 2 | 0 | 0 | 0 | 0 | 0 | Trauma | 5 | N | N |
| A18 | Y | Verio | 57 | 20 | 4 | L/L | 90 | 4 | 22.5 | 60 | 1 | 60 | 60 | 0 | Trauma | 5 | N | N |
| A19 | Y | Verio | 59 | 40 | 2 | L/L | 96 | 2 | 48 | 91 | 4 | 22.75 | 0 | 47.5 | Trauma | 0 | Y | N |
| A20 | Y | Verio | 58 | 27 | 2 | L/R | 70 | 2 | 35 | 90 | 2 | 45 | 20 | 15 | Inf. | 5 | N | Y |
| A21 | Y | Verio | 53 | 28 | 4 | L/R | 20 | 2 | 10 | 40 | 2 | 20 | 0 | 15 | Trauma | 5 | N | Y |
| A22 | Y | Verio | 46 | 38 | 4 | L/R | 90 | 1 | 90 | 94 | 1 | 94 | 90 | 20 | Trauma | 0 | Y | N |
| A23 | Y | Verio | 24 | 18 | 4 | R/L | 100 | 1 | 100 | 90 | 2 | 45 | 0 | 35 | Trauma | 0 | N | Y |
| A24 | Y | Verio | 49 | 37 | 2 | L/R | 20 | 1 | 20 | 80 | 3 | 26.7 | 0 | 0 | Trauma | 1 | Y | N |
| A25 | Y | Verio | 50 | 45 | 2 | L/L | 90 | 1 | 90 | 70 | 1 | 70 | 40 | 16.7 | Tumour | 2 | N | N |
| A26 | Y | Verio | 25 | 18 | 5 | L/R | 100 | 1 | 100 | 30 | 1 | 30 | 10 | 18 | Trauma | 2 | N | N |
| A27 | Y | Verio | 45 | 20 | 4 | R/L | 50 | 1 | 50 | 50 | 5 | 10 | 0 | 40 | Trauma | 2 | N | Y |